Manulife (Manufacturers Life Insurance)
FBLG icon

Manulife (Manufacturers Life Insurance)’s FibroBiologics FBLG Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-505
Closed -$20.2K – 2997
2024
Q4 		$20.2K Sell
505
-8
-2% -$429 ﹤0.01% 2962
2024
Q3 		$31.7K Buy
+513
New +$34.1K ﹤0.01% 2989

Other funds holding FBLG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAS
Optivise Advisory Services Franklin, Tennessee $197M AUM 26.07% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s FBLG Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of FibroBiologics (FBLG) in Q1 2025, closing a stake of 505 shares — an estimated $20.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in FBLG in Q3 2024 and held it in 2 quarters. The position peaked at $31.7K in Q3 2024. 65 funds tracked by Wall St. Rank hold FBLG as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining FibroBiologics position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 505 FibroBiologics shares in Q1 2025, an estimated $20.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in FibroBiologics in Q3 2024 and held it in 2 quarters.
  • Manulife (Manufacturers Life Insurance)'s FibroBiologics position peaked at $31.7K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.